Peripheral Stent Study Design Panel, Endpoint Data Development Urged
This article was originally published in The Gray Sheet
Executive Summary
FDA should establish a cross-disciplinary committee to aid manufacturers designing clinical trials supporting PMAs for iliac artery stenting and other peripheral indications, vascular interventionalists advised the agency's Circulatory System Devices Panel at an April 23 meeting in Silver Spring, Maryland.
You may also be interested in...
Off-Label Practices Plague Circulatory System Device Randomized Trials
Off-label use of biliary stents is hindering superficial femoral artery (SFA) device development, CDRH Division of Cardiovascular Devices Director Bram Zuckerman told participants at CRT 2004 in Washington, D.C
Off-Label Practices Plague Circulatory System Device Randomized Trials
Off-label use of biliary stents is hindering superficial femoral artery (SFA) device development, CDRH Division of Cardiovascular Devices Director Bram Zuckerman told participants at CRT 2004 in Washington, D.C
IntraTherapeutics IntraCoil PMA Foiled By Widespread Off-Label Stenting
Sulzer/IntraTherapeutics said it will continue efforts to win FDA approval of its IntraCoil stent for use in the popliteal and femoral arteries, despite the rampant off-label use of other stents for the indication.